Myllia Biotechnology combines CRISPR screening with single-cell RNA sequencing, leveraging two transformative technologies to enable genetic screening for complex phenotypes. We utilize the CRISPR screening workflow to map the impact of thousands of genetic perturbations on the global transcriptome at single-cell resolution, thus effectively establishing a paradigm for next-generation CRISPR screens.
Our powerful approach has broad applications in identifying novel drug targets or elucidating unknown mechanisms of actions (MoA) of drugs. Each screening project is customized to the specific needs of our clients and we perturb cells with CRISPR KO, CRISPR interference or CRISPR activation coupled to high-content read-outs such as fitness, FACS and single-cell transcriptomics. Notably, we offer single-cell CRISPR screens (CROP-Seq) in cancer cells and primary immune cells, including primary human T cells to support biotech and pharma companies striving to develop novel CAR-T and TCR-T cell therapeutics.
Company Details
- Employees
- 24
- Founded
- -
- Address
- Am Kanal 27, Vienna,1110,austria
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- aelian.bio
- Keywords
- Functional Genomics, Pooled CRISPR Screening, Early R&D, Target Identification, Drug Discovery, T Cell Biology, Immunology, Oncology, Transcriptomics, Single-Cell RNA Sequencing, Flow Cytometry, Genomics Service Provider, Assay Development, Project Management, Customized CRISPR gRNA Design, Targeted Sequencing, Bioinformatics, CRISPR KO Screens, CRISPR Interference Screens.
- HQ
- Vienna
Myllia Biotechnology Questions
Myllia Biotechnology's website is aelian.bio
Myllia Biotechnology's LinkedIn profile is https://at.linkedin.com/company/mylliabio
Myllia Biotechnology has
24 employees.
View email and phone details for 24
employees at Myllia Biotechnology.
Myllia Biotechnology's industry is
Biotechnology Research
Myllia Biotechnology's top competitors are
Proxygen,
Vienna Biocenter,
Lexogen,
Bit.bio Discovery,
Oncoone,
Viverita Therapeutics,
Biotech Austria,
Hookipa Pharma Inc.,
Ribbon Bio,
A:head Bio Ag.
Myllia Biotechnology's categories are Biotechnology Research
Myllia Biotechnology's founding year is 2018
